| Patent | Date |
|---|
Solid dispersion forms of rifaximin
Grant 11,311,521 - Golden , et al. April 26, 2 | 2022-04-26 |
Solid Dispersion Forms Of Rifaximin
App 20220040157 - Golden; Pam ; et al. | 2022-02-10 |
Methods For Treating Irritable Bowel Syndrome (ibs)
App 20220031675 - Forbes; William ; et al. | 2022-02-03 |
Solid Dispersion Forms Of Rifaximin
App 20210401813 - Golden; Pam ; et al. | 2021-12-30 |
Solid dispersion forms of rifaximin
Grant 11,129,817 - Golden , et al. September 28, 2 | 2021-09-28 |
Methods Of Treating Hepatic Encephalopathy
App 20210275507 - Forbes; William | 2021-09-09 |
Solid Dispersion Forms Of Rifaximin
App 20210205279 - Golden; Pam ; et al. | 2021-07-08 |
Use Of Methylnaltrexone To Attenuate Tumor Progression
App 20210121456 - Moss; Jonathan ; et al. | 2021-04-29 |
Solid dispersion forms of rifaximin
Grant 10,874,647 - Golden , et al. December 29, 2 | 2020-12-29 |
Formulations Of Rifaximin And Uses Thereof
App 20200397904 - Selbo; Jon ; et al. | 2020-12-24 |
Methods Of Treating Hepatic Encephalopathy
App 20200368213 - Forbes; William | 2020-11-26 |
Methods for treating irritable bowel syndrome (IBS)
Grant 10,765,667 - Forbes , et al. Sep | 2020-09-08 |
Methods For Retreating Irritable Bowel Syndrome (ibs)
App 20200276170 - Golden; Pam ; et al. | 2020-09-03 |
Electrolyte Purgative
App 20200268790 - Borody; Thomas Julius ; et al. | 2020-08-27 |
Methods For Retreating Irritable Bowel Syndrome (ibs)
App 20200230116 - Golden; Pam ; et al. | 2020-07-23 |
Methods of treating hepatic encephalopathy
Grant 10,709,694 - Forbes | 2020-07-14 |
Methods For Treating Irritable Bowel Syndrome (ibs)
App 20200206199 - Forbes; William ; et al. | 2020-07-02 |
Use Of Methylnaltrexone To Attenuate Tumor Progression
App 20200163958 - Moss; Jonathan ; et al. | 2020-05-28 |
Methods For Treating Irritable Bowel Syndrome (ibs)
App 20200121653 - Forbes; William ; et al. | 2020-04-23 |
Methods for retreating irritable bowel syndrome (IBS)
Grant 10610522 - | 2020-04-07 |
Use Of Aminosalicylates In Diarrhoea-predominent Irritable Bowel Syndrome
App 20200101090 - Shortis; Nicolas Peter | 2020-04-02 |
IBS microbiota and uses thereof
Grant 10,493,064 - Golden , et al. De | 2019-12-03 |
Methods for treating irritable bowel syndrome (IBS)
Grant 10,456,384 - Forbes , et al. Oc | 2019-10-29 |
Gastric And Colonic Formulations And Methods For Making And Using Them
App 20190240229 - Borody; Thomas Julius ; et al. | 2019-08-08 |
Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
Grant 10,328,088 - Shortis | 2019-06-25 |
Gastric and colonic formulations and methods for making and using them
Grant 10,092,573 - Borody , et al. October 9, 2 | 2018-10-09 |
Use Of Aminosalicylates In Diarrhoea-predominent Irritable Bowel Syndrome
App 20180250315 - Shortis; Nicolas Peter | 2018-09-06 |
Rifaximin derivative and uses thereof
Grant 9,725,466 - Golden , et al. August 8, 2 | 2017-08-08 |
Use Of Methylnaltrexone To Attenuate Tumor Progression
App 20170202832 - Moss; Jonathan ; et al. | 2017-07-20 |
Ibs Microbiota And Uses Thereof
App 20170151220 - Golden; Pam ; et al. | 2017-06-01 |
Methods For Retreating Irritable Bowel Syndrome (ibs)
App 20170105977 - Golden; Pam ; et al. | 2017-04-20 |
Balsalazide Formulations And Manufacture And Use Thereof
App 20160279153 - Lockhart; Joseph ; et al. | 2016-09-29 |
Rifaximin Derivative And Uses Thereof
App 20160257700 - Golden; Pam ; et al. | 2016-09-08 |
Method for preparing a rifaximin product
Grant 9,273,063 - Vecchio , et al. March 1, 2 | 2016-03-01 |
Forms of rifaximin and uses thereof
Grant 9,273,066 - Gushurst , et al. March 1, 2 | 2016-03-01 |
Methods For Treating Bowel Diseases
App 20160000765 - Forbes; William ; et al. | 2016-01-07 |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Grant 9,192,616 - Johnson November 24, 2 | 2015-11-24 |
Laxative Compositions And Methods For Treating Constipation And Related Gastrointestinal Diseases And Conditions
App 20150216806 - Borody; Thomas Julius | 2015-08-06 |
Methods Of Administering Rifaximin Without Producing Antibiotic Resistance
App 20150164868 - Pimentel; Mark ; et al. | 2015-06-18 |
Rifaximin derivative and uses thereof
Grant 9,035,046 - Golden , et al. May 19, 2 | 2015-05-19 |
Forms of rifaximin and uses thereof
Grant 9,034,892 - Gushurst , et al. May 19, 2 | 2015-05-19 |
Method Of Treating Ulcerative Colitis
App 20150132284 - Forbes; William P. ; et al. | 2015-05-14 |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Grant 8,921,344 - Johnson December 30, 2 | 2014-12-30 |
Methods Of Treating Ulcerative Colitis
App 20140349982 - Forbes; William ; et al. | 2014-11-27 |
Method For Treating Ulcerative Colitis
App 20140349983 - Forbes; William P. ; et al. | 2014-11-27 |
Colonic purgative composition with soluble binding agent
Grant 8,507,009 - Skiendzielewski , et al. August 13, 2 | 2013-08-13 |
Formulations And Uses Of 2-hydroxy-5-phenylazobenzoic Acid Derivatives
App 20130065862 - Johnson; Lorin | 2013-03-14 |
Balsalazide formulations and manufacture and use thereof
App 20090252788 - Lockhart; Joseph ; et al. | 2009-10-08 |
Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
App 20080306029 - Bettenhausen; Doug ; et al. | 2008-12-11 |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
Grant 7,452,872 - Johnson November 18, 2 | 2008-11-18 |
Polyethylene glycol colonic purgative composition
App 20080260682 - Rose; Martin ; et al. | 2008-10-23 |
Colonic purgative composition with soluble binding agent
App 20080213393 - Skiendzielewski; Stephen ; et al. | 2008-09-04 |
Formulations And Uses Of 2-hydroxy-5-phenylazobenzoic Acid Derivatives
App 20080096849 - Johnson; Lorin | 2008-04-24 |
Formulations And Uses Of 2-hydroxy-5-phenylazobenzoic Acid Derivatives
App 20070265232 - Johnson; Lorin | 2007-11-15 |
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
Grant 5,905,073 - Johnson , et al. May 18, 1 | 1999-05-18 |
| 